Skip to main content
Erschienen in: Journal of Gastrointestinal Cancer 3/2015

01.09.2015 | Original Research

Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer

verfasst von: Durgatosh Pandey, Pankaj Kumar Garg, N. M. L. Manjunath, Jyoti Sharma

Erschienen in: Journal of Gastrointestinal Cancer | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Involvement of extrahepatic bile duct in gallbladder cancer (GBC) is considered a sign of advanced disease; resection of extrahepatic bile duct in GBC has been a contentious issue considering the poor prognosis of the disease.

Methods

This retrospective study was done in two tertiary teaching hospitals of North India. The case records of all the GBC patients who underwent radical cholecystectomy with extra-hepatic bile duct resection were reviewed. Details concerning the clinical presentation, preoperative therapy, operative procedure, indication of bile duct resection, postoperative complications and outcome were retrieved from the case records. Kaplan–Meier analysis was done to estimate median disease-free survival and overall survival.

Results

There were 17 GBC patients who underwent radical cholecystectomy with resection of extrahepatic bile duct. Median age of the patients was 51 years (range 35–62); male to female ratio was 5:12. Six patients were diagnosed after histopathological examination of resected gallbladder specimen following cholecystectomy (incidental gallbladder cancer). All the patients had R‘0’ resection. The indication for extra-hepatic bile duct resection was direct infiltration of hepatoduodenal ligament in nine, positive cystic duct margin in two, densely adherent pericholedochal lymphnodes in one and associated ampullary growth in one patient. Kaplan–Meier analysis predicted median disease-free survival of 20 months and median overall survival of 26 months.

Conclusion

Extrahepatic bile duct resection to achieve R‘0’ resection in the management of advanced gallbladder cancer is safe with acceptable postoperative morbidity and has potential to improve survival.
Literatur
1.
Zurück zum Zitat Nandakumar A, Gupta PC, Gangadharan P, et al. Geographical pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005;116:740–54.PubMedCrossRef Nandakumar A, Gupta PC, Gangadharan P, et al. Geographical pathology revisited: development of an atlas of cancer in India. Int J Cancer. 2005;116:740–54.PubMedCrossRef
2.
Zurück zum Zitat Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.PubMedCrossRef Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.PubMedCrossRef
3.
Zurück zum Zitat Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.PubMedCrossRef Garg PK, Pandey D, Sharma J. The surgical management of gallbladder cancer. Expert Rev Gastroenterol Hepatol. 2015;9:155–66.PubMedCrossRef
4.
Zurück zum Zitat Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18:307–24.PubMedCrossRef Reddy SK, Clary BM. Surgical management of gallbladder cancer. Surg Oncol Clin N Am. 2009;18:307–24.PubMedCrossRef
5.
Zurück zum Zitat Garg PK, Khurana N, Hadke NS. Subcutaneous and breast metastasis from asymptomatic gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2009;8:209–11.PubMed Garg PK, Khurana N, Hadke NS. Subcutaneous and breast metastasis from asymptomatic gallbladder carcinoma. Hepatobiliary Pancreat Dis Int. 2009;8:209–11.PubMed
6.
Zurück zum Zitat Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center. Ann Surg. 2005;241:385–94.PubMedCentralPubMedCrossRef Dixon E, Vollmer CM, Sahajpal A, et al. An aggressive surgical approach leads to improved survival in patients with gallbladder cancer: a 12-year study at a North American center. Ann Surg. 2005;241:385–94.PubMedCentralPubMedCrossRef
8.
Zurück zum Zitat D’Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806–16.PubMedCrossRef D’Angelica M, Dalal KM, DeMatteo RP, et al. Analysis of the extent of resection for adenocarcinoma of the gallbladder. Ann Surg Oncol. 2009;16:806–16.PubMedCrossRef
9.
Zurück zum Zitat Butte JM, Matsuo K, Gonen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.PubMedCrossRef Butte JM, Matsuo K, Gonen M, et al. Gallbladder cancer: differences in presentation, surgical treatment, and survival in patients treated at centers in three countries. J Am Coll Surg. 2011;212:50–61.PubMedCrossRef
10.
Zurück zum Zitat Eil R, Hansen PD, Cassera M, et al. Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res. 2013;6:101–5.PubMedCentralPubMed Eil R, Hansen PD, Cassera M, et al. Bile duct involvement portends poor prognosis in resected gallbladder carcinoma. Gastrointest Cancer Res. 2013;6:101–5.PubMedCentralPubMed
11.
Zurück zum Zitat Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.PubMedCrossRef Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.PubMedCrossRef
12.
Zurück zum Zitat Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 2007;14:2831–7.PubMedCrossRef Agarwal AK, Mandal S, Singh S, et al. Biliary obstruction in gall bladder cancer is not sine qua non of inoperability. Ann Surg Oncol. 2007;14:2831–7.PubMedCrossRef
13.
Zurück zum Zitat Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef Pandey D. Technical description of a regional lymphadenectomy in radical surgery for gallbladder cancer. HPB (Oxford). 2012;14:216–9.CrossRef
14.
Zurück zum Zitat Pandey D. Jaundice after radical cholecystectomy and bile duct resection: a case of postoperative acute viral hepatitis A confounding the clinical picture. Indian J Surg Oncol. 2011;2:210–1.PubMedCentralPubMedCrossRef Pandey D. Jaundice after radical cholecystectomy and bile duct resection: a case of postoperative acute viral hepatitis A confounding the clinical picture. Indian J Surg Oncol. 2011;2:210–1.PubMedCentralPubMedCrossRef
15.
Zurück zum Zitat Sakamoto Y, Kosuge T, Shimada K, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006;94:298–306.PubMedCrossRef Sakamoto Y, Kosuge T, Shimada K, et al. Clinical significance of extrahepatic bile duct resection for advanced gallbladder cancer. J Surg Oncol. 2006;94:298–306.PubMedCrossRef
16.
Zurück zum Zitat Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136:1012–7.PubMedCrossRef Shimizu Y, Ohtsuka M, Ito H, et al. Should the extrahepatic bile duct be resected for locally advanced gallbladder cancer? Surgery. 2004;136:1012–7.PubMedCrossRef
17.
Zurück zum Zitat Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467–73.PubMed Nakamura S, Sakaguchi S, Suzuki S, Muro H. Aggressive surgery for carcinoma of the gallbladder. Surgery. 1989;106:467–73.PubMed
18.
Zurück zum Zitat Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239–45.PubMedCrossRef Matsumoto Y, Fujii H, Aoyama H, et al. Surgical treatment of primary carcinoma of the gallbladder based on the histologic analysis of 48 surgical specimens. Am J Surg. 1992;163:239–45.PubMedCrossRef
19.
Zurück zum Zitat Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–22.PubMedCrossRef Tsukada K, Hatakeyama K, Kurosaki I, et al. Outcome of radical surgery for carcinoma of the gallbladder according to the TNM stage. Surgery. 1996;120:816–22.PubMedCrossRef
20.
Zurück zum Zitat Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639–46.PubMedCentralPubMedCrossRef Bartlett DL, Fong Y, Fortner JG, et al. Long-term results after resection for gallbladder cancer. Implications for staging and management. Ann Surg. 1996;224:639–46.PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Araida T, Higuchi R, Hamano M, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009;39:770–9.PubMedCrossRef Araida T, Higuchi R, Hamano M, et al. Should the extrahepatic bile duct be resected or preserved in R0 radical surgery for advanced gallbladder carcinoma? Results of a Japanese Society of Biliary Surgery Survey: a multicenter study. Surg Today. 2009;39:770–9.PubMedCrossRef
22.
Zurück zum Zitat Wiggers JK, Groot Koerkamp B, Ovadia Z, et al. Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB (Oxford). 2013. doi:10.1111/hpb.12188. Wiggers JK, Groot Koerkamp B, Ovadia Z, et al. Patterns of recurrence after resection of gallbladder cancer without routine extrahepatic bile duct resection. HPB (Oxford). 2013. doi:10.​1111/​hpb.​12188.
23.
Zurück zum Zitat Choi SB, Han HJ, Kim WB, et al. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbecks Arch Surg. 2013;398:1137–44.PubMedCrossRef Choi SB, Han HJ, Kim WB, et al. Surgical strategy for T2 and T3 gallbladder cancer: is extrahepatic bile duct resection always necessary? Langenbecks Arch Surg. 2013;398:1137–44.PubMedCrossRef
24.
Zurück zum Zitat Yagi H, Shimazu M, Kawachi S, et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg. 2006;13:530–6.PubMedCrossRef Yagi H, Shimazu M, Kawachi S, et al. Retrospective analysis of outcome in 63 gallbladder carcinoma patients after radical resection. J Hepatobiliary Pancreat Surg. 2006;13:530–6.PubMedCrossRef
25.
Zurück zum Zitat Endo I, Shimada H, Fujii Y, et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg. 2001;8:505–10.PubMedCrossRef Endo I, Shimada H, Fujii Y, et al. Indications for curative resection of advanced gallbladder cancer with hepatoduodenal ligament invasion. J Hepatobiliary Pancreat Surg. 2001;8:505–10.PubMedCrossRef
26.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27:260–5.PubMedCrossRef Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatoduodenal ligament invasion by gallbladder carcinoma: histologic patterns and surgical recommendation. World J Surg. 2003;27:260–5.PubMedCrossRef
27.
Zurück zum Zitat Chan KM, Yeh TS, Yu MC, et al. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg. 2005;29:72–5.PubMedCrossRef Chan KM, Yeh TS, Yu MC, et al. Gallbladder carcinoma with biliary invasion: clinical analysis of the differences from nonbiliary invasion. World J Surg. 2005;29:72–5.PubMedCrossRef
28.
Zurück zum Zitat Shukla PJ, Neve R, Barreto SG, et al. A new scoring system for gallbladder cancer (aiding treatment algorithm): an analysis of 335 patients. Ann Surg Oncol. 2008;15:3132–7.PubMedCrossRef Shukla PJ, Neve R, Barreto SG, et al. A new scoring system for gallbladder cancer (aiding treatment algorithm): an analysis of 335 patients. Ann Surg Oncol. 2008;15:3132–7.PubMedCrossRef
29.
Zurück zum Zitat Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138:741–50.PubMedCrossRef Kokudo N, Makuuchi M, Natori T, et al. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg. 2003;138:741–50.PubMedCrossRef
30.
Zurück zum Zitat Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.PubMedCrossRef Hawkins WG, DeMatteo RP, Jarnagin WR, et al. Jaundice predicts advanced disease and early mortality in patients with gallbladder cancer. Ann Surg Oncol. 2004;11:310–5.PubMedCrossRef
31.
Zurück zum Zitat Nimura Y. Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford). 2008;10:183–5.CrossRef Nimura Y. Radical surgery: vascular and pancreatic resection for cholangiocarcinoma. HPB (Oxford). 2008;10:183–5.CrossRef
32.
Zurück zum Zitat Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.PubMedCrossRef Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.PubMedCrossRef
33.
Zurück zum Zitat Sasaki R, Takahashi M, Funato O, et al. Hepatopancreatoduodenectomy with wide lymph node dissection for locally advanced carcinoma of the gallbladder: long term results. Hepatogastroenterology. 2002;49:912–5.PubMed Sasaki R, Takahashi M, Funato O, et al. Hepatopancreatoduodenectomy with wide lymph node dissection for locally advanced carcinoma of the gallbladder: long term results. Hepatogastroenterology. 2002;49:912–5.PubMed
34.
Zurück zum Zitat Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794–800.PubMedCrossRef Sakamoto Y, Nara S, Kishi Y, et al. Is extended hemihepatectomy plus pancreaticoduodenectomy justified for advanced bile duct cancer and gallbladder cancer? Surgery. 2013;153:794–800.PubMedCrossRef
35.
Zurück zum Zitat Lim CS, Jang JY, Lee SE, et al. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer. J Gastrointest Surg. 2012;16:1012–8.PubMedCrossRef Lim CS, Jang JY, Lee SE, et al. Reappraisal of hepatopancreatoduodenectomy as a treatment modality for bile duct and gallbladder cancer. J Gastrointest Surg. 2012;16:1012–8.PubMedCrossRef
36.
Zurück zum Zitat Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg. 2007;14:142–8.PubMedCrossRef Kaneoka Y, Yamaguchi A, Isogai M, et al. Hepatopancreatoduodenectomy: its suitability for bile duct cancer versus gallbladder cancer. J Hepatobiliary Pancreat Surg. 2007;14:142–8.PubMedCrossRef
Metadaten
Titel
Extra-Hepatic Bile Duct Resection: an Insight in the Management of Gallbladder Cancer
verfasst von
Durgatosh Pandey
Pankaj Kumar Garg
N. M. L. Manjunath
Jyoti Sharma
Publikationsdatum
01.09.2015
Verlag
Springer US
Erschienen in
Journal of Gastrointestinal Cancer / Ausgabe 3/2015
Print ISSN: 1941-6628
Elektronische ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-015-9737-9

Weitere Artikel der Ausgabe 3/2015

Journal of Gastrointestinal Cancer 3/2015 Zur Ausgabe

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.